DaleGeoffreySchaarMDPhD

PubMed

• Universal posttransplant cyclophosphamide after allogeneic transplant, a retrospective single institution study.
  Dennis L Cooper, Jacqueline Manago, Vimal Patel, Dale Schaar, Anne Tyno, Yong Lin, Roger Strair> ;Leukemia Research. 2022 Nov 1
• 6 citations
  Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.
  Andrew M Evens, Justin S Brandt, Cody J Peer, Tyler Yin, Dale Schaar, Faheem Farooq, Brett Mozarsky, William D Figg, Elad Sharon> ;American Journal of Hematology. 2022 Jun 1
• Improving patient understanding and outcomes in myelodysplastic syndromes - An animated patient guide to MDS with visual formats of learning.
  David A Sallman, Rafael Bejar, Guillermo Montalban-Bravo, Sandra E Kurtin, Alan F List, Guillermo Garcia-Manero, Stephen D Nimer, Casey L O'Connell, Dale Schaar, Janic...> ;Leukemia Research Reports. 2022 Jan 1
• 1 citations
  The Impact of Prior Salvage Treatment With Immune Checkpoint Inhibitors on Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A S...
  Jiyeon Joy Park, Jenny J. Lin, Esther Huang, Dale G. Schaar> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 May 19
• 8 citations
  Incorporation of posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants: a retrospective, single institution study.
  Dennis L. Cooper, Jacqueline Manago, Vimal Patel, Dale G. Schaar, Tracy Krimmel, Mary Kate McGrath, Anne Tyno, Yong Lin, Roger Strair> ;Bone Marrow Transplantation. 2021 May 1
• 4 citations
  Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy
  Daniel J. Medina, Kevin A. David, Yong Lin, Dale G. Schaar, Vimal Patel, Mecide Gharibo, Rajat Bannerji, Kelly Walton, Joseph Aisner, Arnold B. Rabson, Roger Strair> ;Leukemia & Lymphoma. 2017 May 4
• 45 citations
  Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic st...
  Elan Gorshein, Catherine Wei, Susan Ambrosy, Shanna Budney, Juliana Vivas, Angelika Shenkerman, Jacqueline Manago, Mary Kate McGrath, Anne Tyno, Yong Lin, Vimal Patel,...> ;Clinical Transplantation. 2017 May 1
• 34 citations
  Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia
  Mengning Wang, Chuanwei Yang, Le Zhang, Dale G. Schaar> ;Stem Cells International. 2017 Jan 19
• 20 citations
  PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia.
  Nora M. Barboza, Svetlana Minakhina, Daniel J. Medina, Binaifer Balsara, Sonya Greenwood, Lien Huzzy, Arnold B. Rabson, Ruth Steward, Dale G. Schaar> ;Cancer Biology & Therapy. 2013 Apr 10
• 34 citations
  A phase 2 randomized multicenter study of 2 extended dosing schedules of oral ezatiostat in low to intermediate-1 risk myelodysplastic syndrome
  Azra Raza, Naomi Galili, Scott E. Smith, John E. Godwin, Ralph V. Boccia, Han Myint, Daruka Mahadevan, Deborah Mulford, Mark U. Rarick, Gail L. Brown, Dale G. Schaar, ...> ;Cancer. 2012 Apr 15
• 61 citations
  Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression.
  Yi Ting, Daniel J. Medina, Roger K. Strair, Dale G. Schaar> ;Biochemical and Biophysical Research Communications. 2010 Apr 9
• 2 citations
  Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
  M.J. Levitt, Mecide Gharibo, Roger Strair, Dale G. Schaar, A. Rubin, Joseph R. Bertino> ;Journal of Chemotherapy. 2009 Aug 1
• 109 citations
  miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
  Dale G. Schaar, Daniel J. Medina, Dirk F. Moore, Roger K. Strair, Yi Ting> ;Experimental Hematology. 2009 Feb 1
• 13 citations
  A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies.
  Daniel J. Medina, Mecide Gharibo, Philip Savage, Alan Cohler, Mercy Kuriyan, Binaifer Balsara, Monika Anand, Dale G. Schaar, Tracy Krimmel, Kara Saggiomo, Jacqueline M...> ;Leukemia Research. 2008 Dec 1
• 13 citations
  Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
  Roger K. Strair, Mecide Gharibo, Dale G. Schaar, A. Rubin, Jonathan S. Harrison, Joseph Aisner, Hsin-Ching Lin, Yong Lin, Lauri Goodell, Monika Anand, Binaifer Balsara...> ;Clinical Cancer Research. 2008 Nov 15
• 13 citations
  Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.
  Biren Saraiya, Murugesan Gounder, Jayeeta Dutta, Ahamed Saleem, Celeste Collazo, Luz Zimmerman, Ahamed S. Nazar, Mecide Gharibo, Dale G. Schaar, Yong Lin, Weichung Shi...> ;Anti-Cancer Drugs. 2008 Apr 1
• A call to action: Cancer in adolescents and young adults: An unrecognized healthcare disparity.
  Gibbon, D. G., Schaar, D., Kamen, B.> ;J Pediatr Hematol Oncol. 2006 Sep
• 35 citations
  A phase I clinical trial of 12- O -tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies
  Dale G. Schaar, Lauri Goodell, J. Aisner, Xiao Xing Cui, Zheng Tao Han, Richard L. Chang, John Martin, Stephanie Grospe, Liesel Dudek, Joan Riley, Jacqueline Manago, Y...> ;Cancer Chemotherapy and Pharmacology. 2006 Jun 1
• 11 citations
  12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced dual-specificity phosphatase expression and AML cell survival
  Dale G. Schaar, Hao Liu, Shashi Sharma, Yi Ting, John Martin, Curtis Krier, Marie Ciardella, Mona Osman, Lauri Goodell, Daniel A. Notterman, Roger K. Strair> ;Leukemia Research. 2005 Oct 1
• 23 citations
  Antineoplastic Effects of Partially HLA-Matched Irradiated Blood Mononuclear Cells in Patients With Renal Cell Carcinoma
  Roger K. Strair, Dale G. Schaar, Daniel J. Medina, Mary B. Todd, J. Aisner, Robert S. DiPaola, Jacqueline Manago, Beth Knox, Amanda Jenkinson, Rachelle Senzon, Christi...> ;Journal of Clinical Oncology. 2003 Oct 15
• 62 citations
  Administration of a Phorbol Ester to Patients with Hematological Malignancies Preliminary Results from a Phase I Clinical Trial of 12-O-Tetradecanoylphorbol-13-acetate
  Roger K. Strair, Dale G. Schaar, Lauri Goodell, Joseph Aisner, Khew-Voon Chin, Joseph E. Eid, Rachelle Senzon, Xiao Xing Cui, Zheng Tao Han, Beth Knox, Arnold B. Rabso...> ;Clinical Cancer Research. 2002 Aug 1
• 36 citations
  Novel structure of the human GDNF gene
  Dale Woodbury, Dale G. Schaar, Lakshmi Ramakrishnan, Ira B. Black> ;Brain Research. 1998 Aug 24
• 14 citations
  The identification of a novel cDNA preferentially expressed in the olfactory-limbic system of the adult rat
  Dale G. Schaar, Monica R. Varia, Stella Elkabes, Lakshmi Ramakrishnan, Cheryl F. Dreyfus, Ira B. Black> ;Brain Research. 1996 May 20
• 11 citations
  Characterization of the Genomic Structure of the Mouse APLP1 Gene
  Sue Zhong, Kuo Wu, Ira B. Black, Dale G. Schaar> ;Genomics. 1996 Feb 15
• 16 citations
  Developmental regulation of neurotrophin-3 and trk c splice variants in optic nerve gliain vivo
  S. Elkabes, Dale G. Schaar, C.F. Dreyfus, Ira B. Black> ;Neuroscience. 1995 Jun 1
• Join now to see all

Journal Articles

• PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia  
  Barboza, N., Minakhina, S., Medina, D.J., Balsara, B., Greenwood, S., Huzzy, L., Rabson, A.B., Steward, R. and Schaar, D.G., Cancer Biol Ther, 6/1/2013
• A Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome  
  Raza A, Galili N, Smith SE, Godwin J, Boccia RV, Myint H, Mahadevan D, Mulford D, Rarick M, Brown GL, Schaar D, Faderl S, Komrokji RS, List AF, Sekeres M, Cancer, 4/1/2012
• Accelerated R-COP: A Pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate  
  Levitt, M.J., Gharibo, M., Strair, R., Schaar, D., Rubin, A. and Bertino, J.R., J Chemotherapy, 1/1/2009
• A Phase I Clinical Trial of 12-O-tetradecanoylphorbol-13-acetate for Patients with Relapsed/Refractory Malignancies  
  Schaar, D., Goodell, L., Aisner, J., Cui, X., Han, Z., Chang, R., Martin, J., Grospe, S., Dudek, L., Conney, A., Lin, L., Rubin, E.H. and Strair, R.K., Cancer Chemotherapy Pharmacology, 1/1/2006
• A Call to Action: Cancer in Adolescents and Young Adults: an Unrecognized Healthcare Disparity  
  Gibbon, Darlene G., Schaar, Dale and Kamen, Barton, Journal of Pediatric Hematology and Oncology, 1/1/2006
• 12-O-tetradecanoylphorbol-13-acetate (TPA)-Induced Dual-Specificity Phosphatase Expression and AML Cell Survival  
  Schaar, D.G., Liu, H., Sharma, S., Ting, Y., Martin, J., Krier, C., Ciardella, M., Osman, M., Goodell, L., Notterman, D.A. and Strair, R.K., Leukemia Research, 1/1/2005
• Antineoplastic Effects of Partially HLA-Matched Irradiated Blood Mononuclear Cells in Patients with Renal Cell Carcinoma  
  Strair RK, Schaar D, Medina, D., Todd, M.B., Aisner, J., Dipaola, R.S., Manago, J., Knox, B., Jenkison, A., Senzon, R., Baker, C., Dudek, L., Ciardella, M., Kuriyan, M..., Journal of Clinical Oncology, 1/1/2003
• Administration of a phorbol ester to patients with hematologic malignancies: Preliminary results from a phase I clinical trial of 12-0-tetradecanoylphorbol-13-acetate  
  Strair RK, Schaar D, Goodell L, Aisner J, Chin K-V, Eid J, et al, Clinical Cancer Research, 1/1/2002
• Novel structure of the human GDNF gene  
  Woodbury, D., Schaar, D.G., Ramakrishnan, L. and Black, I.B., Brain Research, 1/1/1998
• The identification of a novel cDNA preferentially expressed in the olfactory-limbic system of the adult rat  
  Schaar, D.G., Varia, M.R., Elkabes, S., Ramakrishnan, L., Dreyfus, C.F. and Black, I.B., Brain Research, 1/1/1996
• Embryonic sensory development: Local expression of neurotrophin-3 and target expression of nerve growth factor  
  Elkabes, S., Dreyfus, C.F., Schaar, D.G. and Black, I.B, J Comp Neurol, 1/1/1994
• Alternative splice forms of the murine T-cell receptor ß transcript in a cytotoxic T-cell line  
  Schaar, D.G., Oh, B.S., Kallay, L.M., Doherty, P.J. and Pan, S., Immunol Invest, 1/1/1990
• Join now to see all

Abstracts/Posters

• Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S...
  Dale Schaar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Dual-Specificity MAPK Phosphatases (DS-MKPs): novel targets for AML therapy.
  Schaar, D.G., Ting, Y. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2006
• Novel Strategies Targeting Pro-Survival Pathways in AML.
  Schaar, D.G., Liu, H., Sharma, S., Ting, Y., Martin, J., Krier, C., Ciardella, M., Osman, M., Goodell, L., Notterman, D.A. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2005
• Phorbol Ester Therapy for Myelogenous Leukemia.
  Schaar, D.G., Osman, M., Ciardella, M., Goodell, L. and Strair, R.K., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2003
• 12-0-tetradecanoylphorbol-13-acetate (TPA)-induced CD9 expression in primary human leukemic cells involves the extracellular signal-regulated kinase (ERK) pathway.
  Schaar, D.G., Osman, M, Goodell, L., Rabson, A. and R. Strair, Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2002
• 12-0-tetradecanoylphorbol-13-acetate (TPA) for patients with relapsed/refractory hematologic malignancies/bone marrow disorders.
  Schaar, D.G., Conney, A., Goodell, L., Chang, R., Chin, K.V., Rabson, A., Hsu, J., Knox, B., Senzon, R., Ciardella, M. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2001
• Differential display of basic FGF-treated cultured cortical type 1 astrocytes.
  Varia, M.R., Schaar, D.G, Dreyfus, C.F. and Black, I.B., Differential Display Meeting, 1/1/1995
• Differential display of basic FGF-treated cultured cortical type 1 astrocytes.
  Varia, M.R., Schaar, D.G., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 25th Annual Meeting, 1/1/1995
• Characterization of the genomic structure of the mouse APLP1 gene: Insight into the molecular complexity of the synapse.
  Zhong, S., Wu, K., Schaar, D. and Black, I.B., Society for Neuroscience 25th Annual Meeting, 1/1/1995
• Analysis of astrocyte PCR products obtained with degenerative primers to TGF-beta/GDNF.
  Dean, D.O., Schaar, D.G., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 24th Annual Meeting, 1/1/1994
• Basic FGF elicits specific changes in morphology and gene expression in cultured cortical type 1 astrocytes.
  Varia, M.R., Schaar, D.G., Wu, H., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 24th Annual Meeting, 1/1/1994
• Differential expression of a peroxisomal membrane protein gene in type 1 astrocytes identified by a PCR-based subtractive cloning methodology.
  Varia, M.R., Schaar, D.G., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 23rd Annual Meeting, 1/1/1993
• Differential glial gene expression in the rat brain.
  Schaar, D.G., Sherwood, A.C., Sieber, B.-A., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 22nd Annual Meeting, 1/1/1992
• Retrovirus-mediated transfer of human IL-2 into mouse hematopoietic stem cells. Cellular Immunity and the Immunotherapy of Cancer.
  Schaar, D.G. and Pan, S., UCLA Symposia on Molecular and Cellular Biology, 1/1/1990
• Alternative splicing of T-cell receptor beta mRNA.
  Schaar, D.G. and Pan, S., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/1989
• Join now to see all

Other

• The expression of a murine cytotoxic T-cell receptor and the lymphokine, interleukin-2, as a result of retrovirus-mediated gene transfer. Ph.D. Thesis. 
  Schaar, D.G.
  1/1/1991